FDA Says It's Taking Steps To Simplify Combo Product Consultations

The agency released an internal assessment of how it handles intercenter consultations for combination products. As expected, there are some serious challenges to collaboration between the centers, but FDA says it is taking tangible steps to make it better.

More from Regulation

More from Policy & Regulation